Merck KGaA (FRA: MRK) recently received a number of ratings updates from brokerages and research firms:

  • 8/4/2017 – Merck KGaA was given a new €106.00 ($124.71) price target on by analysts at Deutsche Bank AG. They now have a “neutral” rating on the stock.
  • 8/4/2017 – Merck KGaA had its “neutral” rating reaffirmed by analysts at J P Morgan Chase & Co.
  • 8/4/2017 – Merck KGaA was given a new €110.00 ($129.41) price target on by analysts at Goldman Sachs Group, Inc. (The). They now have a “neutral” rating on the stock.
  • 8/3/2017 – Merck KGaA was given a new €110.00 ($129.41) price target on by analysts at S&P Global. They now have a “buy” rating on the stock.
  • 8/3/2017 – Merck KGaA was given a new €116.00 ($136.47) price target on by analysts at Warburg Research. They now have a “neutral” rating on the stock.
  • 8/3/2017 – Merck KGaA was given a new €100.00 ($117.65) price target on by analysts at Nord/LB. They now have a “neutral” rating on the stock.
  • 8/3/2017 – Merck KGaA was given a new €109.00 ($128.24) price target on by analysts at Commerzbank Ag. They now have a “neutral” rating on the stock.
  • 8/3/2017 – Merck KGaA was given a new €110.00 ($129.41) price target on by analysts at Berenberg Bank. They now have a “neutral” rating on the stock.
  • 7/31/2017 – Merck KGaA was given a new €119.00 ($140.00) price target on by analysts at Kepler Capital Markets. They now have a “buy” rating on the stock.
  • 7/27/2017 – Merck KGaA was given a new €110.00 ($129.41) price target on by analysts at Goldman Sachs Group, Inc. (The). They now have a “neutral” rating on the stock.
  • 7/26/2017 – Merck KGaA was given a new €106.00 ($124.71) price target on by analysts at Credit Suisse Group. They now have a “neutral” rating on the stock.
  • 7/26/2017 – Merck KGaA was given a new €110.00 ($129.41) price target on by analysts at Berenberg Bank. They now have a “neutral” rating on the stock.
  • 7/26/2017 – Merck KGaA was given a new €106.00 ($124.71) price target on by analysts at Deutsche Bank AG. They now have a “neutral” rating on the stock.
  • 7/26/2017 – Merck KGaA was given a new €100.00 ($117.65) price target on by analysts at J P Morgan Chase & Co. They now have a “neutral” rating on the stock.
  • 7/18/2017 – Merck KGaA had its “sell” rating reaffirmed by analysts at DZ Bank AG.
  • 7/7/2017 – Merck KGaA was given a new €116.00 ($136.47) price target on by analysts at Warburg Research. They now have a “neutral” rating on the stock.
  • 6/28/2017 – Merck KGaA had its “neutral” rating reaffirmed by analysts at Nord/LB.
  • 6/26/2017 – Merck KGaA was given a new €112.00 ($131.76) price target on by analysts at equinet AG. They now have a “neutral” rating on the stock.
  • 6/26/2017 – Merck KGaA was given a new €115.00 ($135.29) price target on by analysts at Independent Research GmbH. They now have a “neutral” rating on the stock.
  • 6/26/2017 – Merck KGaA was given a new €103.00 ($121.18) price target on by analysts at Morgan Stanley. They now have a “neutral” rating on the stock.
  • 6/20/2017 – Merck KGaA was given a new €116.00 ($136.47) price target on by analysts at Warburg Research. They now have a “neutral” rating on the stock.
  • 6/13/2017 – Merck KGaA was given a new €109.00 ($128.24) price target on by analysts at Commerzbank Ag. They now have a “neutral” rating on the stock.
  • 6/13/2017 – Merck KGaA was given a new €103.00 ($121.18) price target on by analysts at Morgan Stanley. They now have a “neutral” rating on the stock.

Shares of Merck KGaA (FRA MRK) traded down 0.484% during midday trading on Monday, hitting €92.376. 3,055 shares of the stock traded hands. Merck KGaA has a 12-month low of €89.00 and a 12-month high of €115.00. The company’s 50 day moving average price is €103.27 and its 200-day moving average price is €104.45. The stock has a market cap of €40.11 billion and a price-to-earnings ratio of 25.753.

.

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.